- Leanne Tite
- BMJ
The pharmaceutical company Wyeth has launched a campaign to persuade the UK government to extend the use of its children's pneumococcal vaccine to all children under the age of 2. Currently, the Department of Health recommends it use only in children who are at risk because of chronic disease.
The move follows recent data published in the New England Journal of Medicine showing indications of an early success for the US paediatric pneumococcal immunisation programme (2003;348:1737-46). Figures compiled by the Centers for Disease Control and Prevention, …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The word parameter is almost always wrong.
Published 25 May 2012
Re: Television shows and education about sexually transmitted infections: no laughing matter
Published 25 May 2012
Re: David Morrell
Published 25 May 2012
Re: Time to end the distinction between mental and neurological illnesses
Published 25 May 2012
Re: Are we nearly there with tranexamic acid?
Published 25 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (8 responses)
Published 2 May 2012
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27